Should You Buy CarMax While It's Below $45?

Shares are down 46% over the past 12 months, but CarMax repurchased $201M of stock last quarter and faces activist pressure from Starboard Value (≈$350M stake) alongside a new CEO, Keith Barr. Recent operating results showed used-unit sales -8%, comparable-store sales -9% and net earnings down >50% YoY; the shares trade at forward and trailing P/Es of ~13 and hit a 52-week high of $82 in Mar 2025. Q4 2025 results are due Apr 14; the turnaround thesis depends on execution of buybacks, operational discipline and consumer demand resilience amid tariff risks.

Analysis

Scale in physical used-car retail is the latent moat most models miss: a national footprint compresses sourcing and reconditioning costs by 200–400bps vs fragmented independents once utilization of centralized reconditioning centers and logistics reaches ~80% capacity. That creates a two-way competitive dynamic — CarMax can defend margins while exerting downward pressure on auction/wholesale prices, pressuring smaller dealers and local auction houses that lack balance-sheet-backed inventory financing.

Key near-term lever arms are EPS-accretive balance-sheet actions and working-capital normalization; buybacks and tighter inventory turns should show measurable EPS lift within 3–12 months if management sticks to repurchase cadence and avoids levering into cyclical risk. The main downside path is macro-driven credit stress (auto-loan delinquencies or a sharp rate shock) that re-prices financing for both retail customers and intermediated wholesale channels, which could force a 20–40% margin reversion scenario over 6–18 months.

From a trading standpoint, the opportunity is asymmetrical: governance-driven capital returns compress float and can amplify upside, but execution risk is binary and clustered around quarterly prints and guidance resets — expect most price moves in a 48–72 hour window around releases. For portfolio construction, size this as an event-driven position (small core + optionality via time-limited calls) and explicitly hedge macro-credit exposure rather than treating it as a pure retail recovery story.

Contrarian view: consensus treats the business as a cyclical retailer, ignoring durable scale effects from proprietary data (pricing, reconditioning outcomes) and fixed-cost leverage in logistics that compound once growth stabilizes. If management converts 50–60% of buyback authorization into open-market repurchases over 12 months, the EPS geometry and float shrink could deliver outsized returns even with tepid unit growth — the market may be underpricing that optionality today.

Key Decisions for Investors

• Long KMX equity (2–4% NAV): build into weakness with a 12–24 month horizon. Target total return +40–60% if EPS accretion and margin recovery materialize; set a tactical stop at -20% and reassess on next-quarter guidance to limit tail-credit exposure.
• Buy 9–12 month KMX call spread (cost ~2–4% NAV): buy a ~0.35-delta long call and sell a higher strike to finance ~50–70% of cost. This offers ~3:1 asymmetric upside if buybacks and operational tweaks show sequential improvement, with defined downside equal to premium paid.
• Pair trade — Long KMX / Short CVNA (equal notional, 6–12 months): play scale and balance-sheet advantage vs higher-capital challenger. Expect relative outperformance if wholesale prices normalize and financing conditions tighten; risk: idiosyncratic event for the short leg.
• Downside hedge for holders: buy 6–9 month puts equal to 5–10% of position size to cap catastrophic credit-cycle losses. Cost is insurance against a sudden macro shock that would otherwise erase equity gains quickly.